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Leukemia  is  a  hematological  disorder  which 
is caused by proliferating white blood cell-form-
ing tissues resulting in a marked increase in cir-
culating immature or abnormal white blood cells. 
Leukemia  arises  from  a  hematopoitetic  stem 
cell characterized by a disordered differentiation 
and proliferation of neoplastic cells.1,2 Leukemia 
is characterized into acute or chronic forms, ac-
cording to its clinical behavior, and characterized 
as  lymphocytic  and  myelocytic,  according  to  its 
histogenetic origin. Acute myeloblastic leukemia 
(AML), which is also known as; acute myelocytic 
leukemia,  acute  granulocytic  leukemia  or  acute 
nonlymphocytic leukemia, is commonly classified 
under 8 subgroups according to the French-Amer-
ican-British (FAB) classification system. However 
in 1997, the World Health Organization proposed 
4 groups in the AML category.2-5 Patient with AML 
generally present with symptoms related to com-
plications of pancytopenia (anemia, neutropenia, 
and thrombocytopenia), including weakness, and 
easy fatigue, infections of variable severity, and/or 
hemorrhagic findings such as gingival bleeding, 
ecchymoses, epistaxis, or menorrhagia. Combina-
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AbstrAct
Acute Myeloblastic Leukemia (AML) is a malignant disease of bone marrow. Due to its high morbidity 
rate, early diagnosis and appropriate medical therapy is essential. Rapidly forming gingival hyperplasia 
is usually the first sign of this disease. This case report describes a 17-year-old female who presented 
rapid gingival overgrowth together with gingival bleeding in only two weeks time. A medical consultation 
was asked from hematology clinics and after a detailed medical examination Acute Monocytic Leuke-
mia (FAB M5) was rendered. Chemotherapy was the choice of treatment. The patient responded well 
to chemotherapeutic induction regimen and after two months of medical therapy disease remised and 
gingival hyperplasia regressed. This case report shows that the gingival hyperplasia may represent an 
initial manifestation of an underlying systemic disease.  Also, early medical therapy in acute monocytic 
leukemia may resolve the gingival hyperplasia that companies the disease progression. (Eur J Dent 
2007;2:111-114)
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Initial Eight weeks after Normal
WBC 8.72 3.94 4-11 x 103 mm3
RBC 2.58 4.37 4.2-5.4 x 106 mm3
HGB 7.8 12.7 12-16 g/dl
HCT 22.4 35.5 37-47 %
PLT 94 269 150-400 x 103 mm3
NEUT 0.65 0.67 1.9-8 x 103 mm3
Table 1. Hematological findings of the patient, before and eight weeks after the initiation of chemother-
apy. WBC: white blood cells; RBC: red blood cells; HGB: hemoglobin; HCT: hematocrit; PLT: platelets; 
NEUT: neutrophil. 
Figure 2. Healing of gingival hyperplasia at the eight week of 
chemotherapy. No periodontal therapy was performed during 
this period. Only meticulous oral hygiene was advised.
Figure 1. Initial intra-oral view of the patient. Enlargement, es-
pecially in the frontal area is prominent. Enlargement widens 
through left side, both in maxilla and mandibula, without ef-
fecting the side right much.
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tions of these symptoms are also common.1-3
Gingival overgrowth is defined as the excessive 
overgrowth of the gingival tissue. Gingival over-
growth  has  several  causes,  including  poor  oral 
hygiene, medications, serious systemic illnesses, 
hematological  disorders,  genetic  conditions  and 
it even can be idiopathic.6-10 Oral manifestation in 
patient with leukemia have been described in all 
subtypes of AML, chronic myeloid leukemia, acute 
lymphocytic  leukemia,  and  chronic  lymphocytic 
leukemia.7  Gingival  infiltration  represents  a  5% 
frequency  as  the  initial  presenting  complication 
of AML.4,5 Gingival infiltration of leukemic cells is 
most commonly seen in acute monocytic leukemia 
(M5) and acute myelomonocytic leukemia (M4).11,12   
Dreizen et al13 evaluated 1076 leukemic patients 
and found gingival involvement in 66.7% of M5 pa-
tients and 18.5% of M4 patients.8,11,13-17  
This report defines an AML patient with rapid 
gingival hyperplasia. The dentist was the first med-
ical examiner who diagnosed the disease, referred 
her to hematology clinics, and after a successful 
chemotherapy  patient’s  gingival  hyperplasia  re-
lapsed together with the remission of the disease.
cAsE rEPort
A  17-year-old  Caucasian  woman  applied  to 
Cumhuriyet University, Faculty of Dentistry, Peri-
odontology Clinic with the chief complaint of severe 
gingival hyperplasia with rapid development in two 
weeks time. Dental examination showed a promi-
nent gingival hyperplasia, in both jaws, especially 
in  the  anterior  region.  Gingival  hyperplasia  was 
involving the buccal, lingual and palatal aspects, 
as well. The gingival was bulbous, pale and lacked 
stippling with local erythematic areas (Figure 1). 
Bone  loss  was  not  evident  in  panoramic  radio-
graph. The dentist avoided from using periodontal 
probe and any periodontal treatment due to the 
unusual patient history. In the same day, the pa-
tient referred to Cumhuriyet University, Faculty of 
Medicine, Hematology Clinic with the preliminary April 2007 - Vol.1
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diagnosis  of  leukemia.  In  medical  examination, 
she suffered from systemic manifestations such 
as  fatigue,  nausea,  vomit,  anorexia,  and  weight 
loss in a month. Complete blood count, peripheral 
blood smear and bone marrow biopsy were taken 
from the patient. Complete blood count displayed 
a decrease in red blood cells with lowered hema-
tocrit and hemoglobin levels (anemia); and a low 
platelet count (thrombocytopenia), although white 
blood cell levels were in normal values, a decrease 
in neutrophil levels (neutropenia) (Table 1). Bone 
marrow biopsy demonstrated 80% hypercellular-
ity, predominated by monoblast cells. Peripheral 
blood smear revealed 52% mostly blast cells. He-
matology clinic diagnosed the case as AML M5 ac-
cording to peripheral blood smear and bone mar-
row biopsy in the several days. After the diagnosis 
of AML M5, The patient was only advised brushing 
her teeth, during the chemotherapy.
Medical Therapy
The patient was given chemotherapy consisting 
of intravenous administration of cytosine arabino-
side (ARA-C, 100 mg/m2/day (200 mg) x 7 days) 
and idarubicin hydrochloride (idamycin, 12 mg/m2/ 
day (12 mg) x 3 days). 
Eight weeks following the initial therapy, com-
plete  blood  count  values  indicated  remission 
(Table 1). Regression of the gingival hyperplasia 
without performing periodontal therapy was also 
prominent (Figure 2). One month later following 
initial  therapy,  monoblast  cells  were  decreased 
from 80% to 5%. The patient was taken into main-
tenance therapy after initial therapy two times for 
two  month.  The  medical  administration  was  in-
cluded; Cytosine arabinoside (ARA-C, 100 mg/m2/
day (200 mg) x 5 days) and idarubicin hydrochlo-
ride (idamycin, 12 mg/m2/ day (12 mg) x 3 days). 
Finally, the patient was transferred to a special 
center for bone marrow transplantation. Although 
we had recalled the patient after chemotherapy 
for periodontal therapy, the patient did not come 
to our clinic. Therefore, we could not have the pa-
tient’s outcomes. 
dIscussIon
Even  there  are  several  etiologies  for  gingi-
val overgrowth; usually each etiology has its own 
overgrowth  characteristics.  For  example,  while 
genetically  induced  gingival  overgrowth  show 
firm, normal coloured (pink), non-inflamed gingi-
val tissues, gingival overgrowth due to blood dys-
crasias are edematous, soft, tender to touch and 
show tendency to bleed.4,5,9,10,18 
Gingival  hyperplasia  is  most  commonly  seen 
with  the  AML  subtypes  acute  monocytic  leuke-
mia (M5) (66.7%), acute myelomonocytic leukemia 
(M4) (18.5%), and acute myelocytic leukemia (M1, 
M2) (3.7%).19 In this case report, a rapid gingival 
hyperplasia  together  with  gingival  bleeding  was 
the main reason of the patient to seek therapy. 
The dentist who examined the patient suspected 
from the duration of the overgrowth, and from the 
spontaneous gingival bleeding, without a promi-
nent microbial dental plaque or calculus accumu-
lation. A systemic disease such as probably one of 
the hematologic diseases was the dentist’s early 
diagnosis,  and  a  hematology  consultation  was 
asked.  Gingival  involvement  is  common  in  AML 
and found in 66.7% of the 1076 leukemic M5 pa-
tients, in a study by Dreizen et al.13   In these kinds 
of patients, a dental therapy driven without hema-
tological consultation could be fatal. The fact that 
gingival hyperplasia are sometimes the first mani-
festation of the disease implies that dental profes-
sionals must be sufficiently familiarized with the 
clinical manifestations of systemic diseases.6,8,11
Also a prominent remission was observed in 
gingival hyperplasia after chemotherapy together 
with peripheral blood values. This shows that, in 
cases like AML, elimination of the factor initiat-
ing  the  gingival  hyperplasia  or  maintaining  the 
ideal systemic condition might give a full success 
in periodontal healing. In this case, our patient’s 
medical  condition  forced  us  to  do  the  medical 
therapy first, because of that the dental therapy of 
the patients was delayed to see the effect of medi-
cal therapy.
Microbial dental plaque increases this gingival 
hyperplasia induced systemic diseases. So, for to-
tally remission of gingival hyperplasia, necessary 
periodontal therapy must be applied after system-
ic status was controlled by chemotherapy.
concLusIons
As a result, this case reminds that dentists and 
physicians should be aware of the importance of 
recognizing oral manifestations of systemic dis-
eases. Although physicians most commonly diag-
nose leukemia, dentists can also diagnose patients European Journal of Dentistry
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with  acute  myelogenous  leukemia.  The  dental 
practitioner should have an awareness of diagnos-
tic signs and complications associated with leu-
kemia to better aid in diagnosis and subsequent 
treatment and management. Medical consultation 
must be essential in dental therapy in such cases. 
This case also shows that gingival overgrowth due 
to acute leukemia is commonly improves by che-
motherapy without any periodontal treatment. 
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